CASC
Cascadian Therapeutics, Inc.
CASC
CASC
Delisted
CASC was delisted on the 8th of March, 2018.
80 hedge funds and large institutions have $71.2M invested in Cascadian Therapeutics, Inc. in 2016 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 21 increasing their positions, 22 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
46% less capital invested
Capital invested by funds: $132M → $71.2M (-$60.5M)
65% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 17
Holders
80
Holding in Top 10
1
Calls
$593K
Puts
$108K
Top Buyers
| 1 | +$939K | |
| 2 | +$909K | |
| 3 | +$428K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$367K |
| 5 |
CAM
ClariVest Asset Management
San Diego,
California
|
+$178K |
Top Sellers
| 1 | -$5.17M | |
| 2 | -$1.14M | |
| 3 | -$444K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$428K |
| 5 |
ARTA
A.R.T. Advisors
New York
|
-$376K |